Rasagiline Mesylate Tablets 1 mg; 30 tablets in HDPE bottle; Rx only; NDC 67877-260-30; Manufactured by Alkem Laboratories Ltd., India; Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054
Published January 25, 2023 · Recall initiated: December 28, 2022
Summary
FDA records drug Class II recall D-0159-2023, published January 25, 2023 and initiated December 28, 2022. Recalling firm: Ascend Laboratories, LLC; Status: Terminated; Reported quantity: 12192 bottles; Lot: Lot # 22140903. Exp. Dec. 2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Substance- A complaint was received of black spots/shiny metallic speck on the tablets.
What to do
Voluntary: Firm initiated · E-Mail
Get an email if RASAGILINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- RASAGILINE
- Manufacturer
- Ascend Laboratories, LLC
- Distributor
- Customers in 19 states: CA, FL, GA, IL, KY, LA, MI, MN, MS, NC, NJ, NY, OH, PA, RI, TN, TX, WA, WI; Puerto Rico
- UPC
- 0367877260303
- Lot
- Lot # 22140903. Exp. Dec. 2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATobramycin Ophthalmic Solution, USP, 0.3%, 5 mL per bottle, Rx Only, Manufactured by: Akorn, Inc., LakeJanuary 25, 2023
- FDATriamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, 1000 Capsules per bottle,January 25, 2023
- FDATobramycin Ophthalmic Solution, USP, 0.3%, 5 mL per dropper bottle, Rx Only, Manufactured by: Akorn, Inc.,January 25, 2023
- FDATriamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, [100 or 1000 ] Capsules perJanuary 25, 2023
- FDATimolol Maleate Ophthalmic Solution, USP, 0.5%, Packaged in (a) 5 mL dropper bottle, NDC 17478-288-10; (b) 10January 25, 2023
- FDALevofloxacin Tablets, USP 500 mg; 50-count bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc.January 25, 2023
Questions about this recall
Was Rasagiline Mesylate Tablets 1 mg; 30 tablets in HDPE bottle; Rx only; NDC 67877-260-30; Manufactured by Alkem Laboratories Ltd., India; Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054 recalled?
Yes. FDA published recall D-0159-2023 on January 25, 2023. Reported hazard: Presence of Foreign Substance- A complaint was received of black spots/shiny metallic speck on the tablets.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: RASAGILINE. UPC: 0367877260303.